Literature DB >> 3300755

Comparison of midazolam by mouth and diazepam i.v. in outpatient oral surgery.

C A O'Boyle, D Harris, H Barry, C McCreary, A Bewley, E Fox.   

Abstract

In a randomized double-blind, parallel groups study, 40 patients undergoing surgical removal of impacted 3rd molar teeth received either midazolam 15 mg orally followed at 35 min by i.v. saline, or oral placebo followed at 35 min by i.v. diazepam 10 mg (Diazemuls). Rapid onset of sedation was seen after midazolam, while the pattern and duration of postoperative sedation, as measured by standard psychometric tests, indicated slower recovery after midazolam than after diazepam. Ratings by the surgeon indicated superior anxiolysis following midazolam and significantly more patients expressed a preference for oral midazolam sedation. Significant, comparable anterograde amnesia was seen with both treatments. No significant cardiovascular complications occurred with either treatment. The findings indicate that rapidly acting oral benzodiazepines such as midazolam provide safe, effect alternatives to i.v. diazepam for conscious sedation in outpatients undergoing minor surgical procedures.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300755     DOI: 10.1093/bja/59.6.746

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

1.  A comparison of propranolol and diazepam for preoperative anxiolysis.

Authors:  J B Dyck; F Chung
Journal:  Can J Anaesth       Date:  1991-09       Impact factor: 5.063

2.  A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients.

Authors:  I-Hsin Lin; Mao-Suan Huang; Pei-Yu Wang; Ta-Sen Huang; See-Yen Chong; Sam Li-Sheng Chen; Hung-Huey Tsai
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

3.  Conscious sedation for the management of dental anxiety in third molar extraction surgery: a systematic review.

Authors:  Matteo Melini; Andrea Forni; Francesco Cavallin; Matteo Parotto; Gastone Zanette
Journal:  BMC Oral Health       Date:  2020-05-28       Impact factor: 2.757

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.